The process of obtaining CE marking under IVDR can be complex, and a solid understanding of it is essential for successful market access in Europe. The diagram below illustrates the necessary steps to achieve CE marking for your IVD.
In Europe, in vitro medical devices are classified following the rules outlined in Annex VIII of the In Vitro Diagnostic Medical Devices Regulation. This means that the classification of a product, which may fall under a particular class in China, Brazil, USA, or Canada, could differ when it enters the European market.
Technical documentation forms a cornerstone requirement for in vitro diagnostics, encompassing all classes, and holds significant importance within the CE-marking process under the In Vitro Diagnostic Medical Device Regulation. This documentation acts as a comprehensive repository, capturing the medical device's design, development, manufacturing, and performance data, ensuring its adherence to the MDR's requirements for safety and performance.
The Quality Management System (QMS) plays a pivotal role in the CE-marking process under IVDR. It serves as a framework that guides IVD manufacturers in upholding the highest quality standards at every stage of the device's lifecycle - from initial design and development to production, distribution, and post-market activities.
For companies without a physical presence in the European Union, appointing an Authorised Representative (EC REP) is an essential requirement. While a local distributor can fulfill this role, opting for a professional and independent EC REP brings numerous advantages.
Manufacturers pursuing CE certification for Class B or higher class devices undergo rigorous audits conducted by Notified Bodies.
Partner with us, and let our regulatory expertise guide you towards regulatory success in Europe!
Or use the contact form below